Fresenius Kabi and Phlow Corp. have joined forces to onshore the manufacture of Epinephrine Injection, USP, an essential medicine long at risk of chronic shortage in the U.S. and widely used in hospitals nationwide. Epinephrine injection is a lifesaving drug indicated for emergency treatment of allergic reactions, including anaphylaxis, in adults and pediatric patients. It is also indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shoc...